What is HC-BUVIR?

HC-BUVIR is a prescription medicine used with other antiviral medicines to treat chronic (lasting a long time) hepatitis C infection in adults. HC-BUVIR should not be taken alone. It is not known if HC-BUVIR is safe and effective in children under 18 years of age.
 With HC-BUVIR, theres hope that you can put Hep C behind you. You may be able to stop thinking about your disease, take the next step, and set a new course.
 
Proven to work
HC-BUVIR, as part of a combination therapy, has been shown to work for genotypes 1, 2, 3, and 4 in just 12 or 24 weeks, depending on your genotype*—Learn about another treatment for genotype 1

*Results are measured 3 months after treatment is completed.
 
Simple dosing
HC-BUVIR is one pill, taken once daily, as part of a combination therapy
HC-BUVIR combination therapy is the first all-oral treatment for genotypes 2 and 3
 
A revolutionary treatment for Hep C
HC-BUVIR is sofosbuvir—a breakthrough medicine that directly targets the Hep C virus What is Armoni? Armoni is a newest medicine, a polymerase inhibitor which has been approved for the treatment of patients with genotype 1 and 4 chronic hepatitis C. Armoni is the first FDA-approved scheme which can be prescribed without treatment with ribavirin or interferon. Research studies have stated that in addition to being highly efficient it also has a relatively low toxicity. More than 1500 participants with genotype 1 hepatitis C took part in one of the clinical studies. The course of treatment lasted over 12 weeks. When the therapy course was completed, the primary goal of treatment was reached in 1456 patients the virus was eliminated. Adverse effects which occurred during the treatment with Armoni were mild and mainly comprised headache and fatigue. How Armoni works? Sofosbuvir in combination with ledipasvir target specific proteins involved in the process of virus replication, thus suppressing the disease progression. When to use Armoni? Armoni has been invented to fight chronic hepatitis C and to be used as a peroral combination anti-virus therapy. The medicine can be successfully administered to HIV-coinfected patients with cirrhosis. In certain cases Armoni may be prescribed for the medical treatment of patients who cant be treated with Interferon for any reason.
Armoni, therefore, is currently one of the most promising medicines created for the treatment of hepatitis C. Its efficacy and safety has been evaluated and proved by six clinical studies involving circa 2 thousand of patients. The use of sofosbuvir + ledipasvir as part of combination therapy instead of Interferon which is known to cause certain adverse effects will significantly improve the quality of life in patients suffering from hepatitis C.

For More Prescription Detail contact us: I